Deccan Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 02-12-2024
- Paid Up Capital ₹ 0.15 M
as on 02-12-2024
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 Cr
as on 02-12-2024
- Revenue -13.07%
(FY 2022)
- Profit -60.11%
(FY 2022)
- Ebitda -35.65%
(FY 2022)
- Net Worth 7.74%
(FY 2022)
- Total Assets 0.57%
(FY 2022)
About Deccan Nutraceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.15 M.
The company has closed loans amounting to ₹8.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Megha Karnani and Navin Karnani serve as directors at the Company.
- CIN/LLPIN
U24232PN2001PTC016408
- Company No.
016408
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deccan Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Megha Karnani  | Director | 22-Feb-2023 | Current |
| Navin Karnani | Director | 17-Dec-2012 | Current |
Financial Performance and Corporate Structure Insights of Deccan Nutraceuticals.
Deccan Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.07% decrease. The company also saw a substantial fall in profitability, with a 60.11% decrease in profit. The company's net worth moved up by a moderate rise of 7.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deccan Nutraceuticals?
Unlock access to Deccan Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 26 Aug 2020 | ₹8.00 Cr | Satisfied |
How Many Employees Work at Deccan Nutraceuticals?
Deccan Nutraceuticals has a workforce of 89 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deccan Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deccan Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
